Interventional Cardiology Fellows Course

Chronic Total Occlusion Summit (CTO)

CRF sponsored event

A new Phase 2 clinical trial looks to confirm the efficacy and safety of Thrombolytic Science LLC’s (TSI) sequential dual-treatment regimen of low-dose tissue plasminogen activator (tPA) and HisproUK (TSI’s mutant prourokinase [proUK]) in ischemic stroke patients. The study follows a recently completed Phase 1 study that confirmed the safety and tolerability of TSI’s regimen in healthy volunteers (n=26).

Tafamidis is the first treatment to improve survival and reduce hospitalizations in a rare heart condition called transthyretin amyloid cardiomyopathy, according to late-breaking research presented in a Hot Line Session at the European Society of Cardiology (ESC) Congress 2018 and published in the New England Journal of Medicine.

While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary artery bypass graft (CABG) surgery compared to vein grafts, it is not known if there are additional benefits with the use of a second artery. This was explored in the ten-year outcomes of the Arterial Revascularisation Trial (ART) presented in a Hot Line Session at the European Society of Cardiology (ESC) Congress 2018, Aug. 25-28 in Munich, Germany.

W. L. Gore & Associates Inc. (Gore) announced the acquisition of Pipeline Medical Technologies Inc., a privately held medical technology company focused on advancing chordal repair for degenerative mitral regurgitation (DMR) via a transcatheter procedure.

The Center for Diagnostic Imaging (CDI) in Miami recently released a list of important preparations patients should make before undergoing a computed tomography (CT) scan.

Transcatheter interventions have become a mainstay in cardiac care as treatments for structural and congenital heart disease transition from open-heart surgery to minimally invasive procedures. These procedures, while minimally invasive for patients, often have added degrees of patient-related and procedural-related complexity. 

The Fysicon QMAPP hemodynamic monitoring system is the newest system to gain FDA clearance. It is about the size of a ream of paper.

Beyond measuring blood flow, pressure, oxygen levels and other vital signs in the cardiac catheterization lab, current hemodynamic monitoring systems are an integral part of clinical reporting. Hemodynamic data from newer systems helps autocompletion of data fields in procedure reports, can automate gathering registry data, and can help interface cath lab patient data with the patient’s electronic medical record (EMR).
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now